MRK 8-K 2026-10-13

Merck & Co., Inc. (MRK) 8-K dated 2026-10-13 — accession 0000310158-26-000237. This URL is the filing, not the MRK hub.

Merck & Co., Inc. (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..

Merck & Co., Inc. filed a 8-K on 2026-10-13. Accession 0000310158-26-000237.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 113.6.

Not investment advice. The MRK SEC hub lists recent forms. The stock page is the research view.